RecruitingPhase 4NCT06084364

Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis

Painful Inflammatory Carpometacarpal-1 Osteoarthritis Treated With Intraarticular Steroids, Saline or an Occupational Therapy Intervention: the PICASSO Trial.


Sponsor

Diakonhjemmet Hospital

Enrollment

354 participants

Start Date

Nov 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A placebo-controlled randomized controlled trial exploring the effect of intraarticular steroids, saline or an occupational therapy intervention in inflammatory carpometacarpal-1 osteoarthritis


Eligibility

Min Age: 40 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Injection of triamcinolone acetonide into the CMC-1 joint, a behavioral approach called Multimodal Occupational therapy for CMC-1 joint OA, and others for people with osteoarthritis thumb. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 40 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGInjection of triamcinolone acetonide into the CMC-1 joint

intraarticular injection with triamcinolone acetonide

BEHAVIORALMultimodal Occupational therapy for CMC-1 joint OA

Patient education, instructions about hand exercises, orthosis and training

DRUGPlacebo

Intraarticular injection with saline


Locations(6)

Nordlands Hospital

Bodø, Norway

Haugesund Rheumatism Hospital

Haugesund, Norway

Diakonhjemmet Hospital

Oslo, Norway

Martina Hansens Hospital

Sandvika, Norway

Stavanger University Hospital

Stavanger, Norway

St Olavs Hospital

Trondheim, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06084364


Related Trials